The National Institutes of Health announces a funding opportunity for SBIR Phase IIB Bridge Awards to support the acceleration of cancer-relevant technologies toward commercialization. This opportunity aims to bridge the gap in development and facilitate clinical trial optional projects. Deadline is May 19, 2026.
Eligibility details are not specified in the grant listing. Contact the funding organization for requirements.
